Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TRPML1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | TRPML1 |
| Key Genes/Proteins | AKT, AMPK, AND, APOE, App, ATG12 |
| Related Diseases | Als, ALS, Alzheimer's disease |
| Linked Hypotheses | 4 hypotheses |
Knowledge base pages for this entity
graph TD
TRPML1["TRPML1"]
TRPML1 -->|"expressed in"| Lysosome["Lysosome"]
TRPML1 -->|"regulates"| Autophagy["Autophagy"]
TRPML1 -->|"causes"| Mucolipidosis_Type_IV["Mucolipidosis Type IV"]
TRPML1 -->|"regulates"| Calcium_Dynamics["Calcium Dynamics"]
TRPML1 -->|"activates"| TFEB["TFEB"]
TRPML1 -.prevents.-> mitochondrial_fragmentation["mitochondrial fragmentation"]
TRPML1 -->|"mediates"| Lysosomal_Calcium_Signaling["Lysosomal Calcium Signaling"]
TRPML1 -->|"involved_in"| Vesicular_Trafficking["Vesicular Trafficking"]
MCOLN1["MCOLN1"] -->|"encodes"| TRPML1
TRPML2["TRPML2"] -->|"co_expressed_with"| TRPML1
TRPML3["TRPML3"] -->|"co_expressed_with"| TRPML1
LYSOSOME["LYSOSOME"] -->|"regulates"| TRPML1
AND["AND"] -->|"regulates"| TRPML1
NEURODEGENERATION["NEURODEGENERATION"] -->|"causes"| TRPML1| Target | Relation | Type | Str |
|---|---|---|---|
| h-5cbf67bf98 | targeted_by | hypothesis | 1.00 |
| h-3cdc8defe3 | targeted_by | hypothesis | 1.00 |
| Lysosome | expressed_in | cell_type | 1.00 |
| Mucolipidosis Type IV | associated_with | disease | 1.00 |
| Mitochondrial Calcium Dynamics | regulates | process | 0.95 |
| Calcium Dynamics | regulates | process | 0.95 |
| Autophagy | regulates | process | 0.95 |
| Mucolipidosis Type IV | causes | disease | 0.95 |
| Mucolipidosis IV | associated_with | disease | 0.95 |
| Lysosomal Calcium Release | mediates | process | 0.95 |
| TFEB | activates | protein | 0.95 |
| mitochondrial fragmentation | prevents | phenotype | 0.92 |
| Vesicular Trafficking | involved_in | process | 0.90 |
| calcium | mediates | compound | 0.90 |
| Calcium Homeostasis | regulates | process | 0.90 |
| Mucolipidosis Type Iv | causes | disease | 0.90 |
| lysosomal trafficking | regulates | process | 0.90 |
| Late Endolysosomal Compartment Enlargement | involved_in | phenotype | 0.90 |
| Lysosomal Calcium Signaling | mediates | process | 0.90 |
| Mitophagy | regulates | process | 0.90 |
| Autophagy | associated_with | process | 0.90 |
| Ion Homeostasis | regulates | process | 0.85 |
| Lipid Homeostasis | regulates | process | 0.85 |
| Mucolipidosis Type Iv | therapeutic_target | disease | 0.85 |
| Ion Homeostasis | involved_in | process | 0.85 |
| Lipid Homeostasis | involved_in | process | 0.85 |
| Lysosomal Storage Disorders | associated_with | disease | 0.85 |
| Cargo Degradation | involved_in | process | 0.80 |
| Mitochondrial Homeostasis | involved_in | process | 0.80 |
| vesicular trafficking | regulates | process | 0.80 |
| cellular homeostasis | contributes_to | process | 0.80 |
| Cellular Adaptation To Nutrient Availability | involved_in | process | 0.75 |
| autophagy pathway | participates_in | pathway | 0.70 |
| Cancer | regulates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ferroptosis | therapeutic_target | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| GENES | expressed_in | gene | 0.60 |
| TRPML2 | expressed_in | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| TRPML2 | associated_with | gene | 0.60 |
| ATG8 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-3cdc8defe3 | targets | hypothesis | 1.00 |
| h-5cbf67bf98 | targets | hypothesis | 1.00 |
| MCOLN1 | encodes | gene | 1.00 |
| 31112550 | mediates | paper | 0.90 |
| Artemisia argyi | activates | drug | 0.90 |
| TRPML3 | interacts_with | protein | 0.80 |
| TRPML2 | interacts_with | protein | 0.80 |
| FERROPTOSIS | therapeutic_target | gene | 0.60 |
| ATG16L1 | activates | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| JUN | regulates | gene | 0.60 |
| SNARE | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| ATM | activates | gene | 0.60 |
| ATR | activates | gene | 0.60 |
| CASP3 | activates | gene | 0.60 |
| CTSB | activates | gene | 0.60 |
| CTSD | activates | gene | 0.60 |
| DYNLL1 | activates | gene | 0.60 |
| EIF4EBP1 | activates | gene | 0.60 |
| GLUT4 | activates | gene | 0.60 |
| HOMER1 | activates | gene | 0.60 |
| JNK1 | activates | gene | 0.60 |
| LC3B | activates | gene | 0.60 |
| MAP1LC3B | activates | gene | 0.60 |
| MAP2 | activates | gene | 0.60 |
| MAPK14 | activates | gene | 0.60 |
| MAPK8 | activates | gene | 0.60 |
| RILP | activates | gene | 0.60 |
| SLC2A4 | activates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| JIP4 | activates | gene | 0.60 |
| metformin | targets | drug | 0.60 |
| ATG12 | activates | gene | 0.60 |
| GAPDH | activates | gene | 0.60 |
| LAMP1 | activates | gene | 0.60 |
| MAP1LC3 | activates | gene | 0.60 |
| MCOLN1 | activates | gene | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| NSF | activates | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| STX17 | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| MCOLN1 | associated_with | gene | 0.60 |
| TRPML2 | expressed_in | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| MCOLN1 | targets | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Spatiotemporal coupling between TRPML1-mediated lysosomal ca | 0.705 | neurodegeneration | What determines the specificity of calci |
| PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5 | 0.584 | neurodegeneration | How does PIKFYVE inhibition activate unc |
| Sequential TRPML1 Activation Following Autophagy Priming | 0.575 | neurodegeneration | Does TRPML1 enhancement cause therapeuti |
| TRPML1-PINK1/Parkin Axis Coordinates Mitophagy with Lysosoma | 0.560 | neurodegeneration | Does TRPML1 enhancement cause therapeuti |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.575
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| PPP3/calcineurin-dependent TFEB dephosphorylation mechanism | exploratory | motoneuron degeneration | 0.800 | 0.00 | neuronal cell lines | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.72 · 2026-04-21
closed · Rounds: 4 · Score: 0.46 · 2026-04-16
Hypotheses and analyses mentioning TRPML1 in their description or question text
No additional research found